Our Dartmouth clinic now offers Spravato® — an FDA-approved, innovative option for adults with treatment-resistant depression (TRD). If you’ve tried two or more antidepressants without relief, Spravato® may help you find new hope.
Spravato® (esketamine nasal spray) is the first and only FDA-approved nasal spray for adults with:
• Treatment-resistant depression (TRD)
• Major depressive disorder (MDD) with suicidal thoughts or actions
Spravato® works differently from traditional antidepressants by targeting glutamate pathways in the brain to help improve mood and relieve symptoms when other medications haven’t worked.
You self-administer the nasal spray under direct medical supervision in our comfortable, private treatment room.
You’ll stay and relax for about 2 hours while our care team monitors you for any side effects
A trusted family member or caregiver will need to drive you home afterward.
To help prevent nausea, avoid eating for 2 hours and drinking for 30 minutes before treatment.
Why Choose Spravato® at BNBA?
At Boston Neurobehavioral Associates, your care comes first.
Our Spravato® program is:
Safe & Certified
We are fully REMS-certified to administer Spravato®.
Covered by Insurance
Most major insurance plans, including Medicaid, are accepted.
Compassionate & Comfortable
Your privacy and well-being matter. Our caring team supports you every step of the way
Is Spravato® Right for You?
Spravato® may help if:
• You’ve tried two or more antidepressants without relief.
• You live with severe depression or have suicidal thoughts that need more support.
Spravato® is not for everyone — certain health conditions or a history of substance misuse may mean it’s not the right fit. Our team will review your full medical history to ensure your safety.